13F Holdings
中文EN

LUCY Innovative Eyewear Inc

Ophthalmic Goods · Nasdaq · SEC CIK 1808377 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY56.9%
TTM net income YoY-3.7%
TTM EPS YoY42.4%
Revenue 3-yr CAGR83.9%
Net income 3-yr CAGR—

Margins

Gross margin22.7%
Operating margin—
Net margin-216.8%
FCF margin—
EBITDA margin—

Returns

ROE-92.4%
ROA-84.0%
ROIC (approx.)—
Asset turnover0.39x

Leverage & solvency

Liabilities / assets10.2%
Debt / equity0.00x
Current ratio9.12x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.89x
Accruals ratio-9.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.66M$1.64M$1.15M$659,788$690,670
Cost of revenue$2.09M$1.42M$1.27M$716,077$542,416
Gross profit$567,451$215,190-$119,329-$56,289$148,254
R&D expense$725,388$819,387$662,184$524,692$86,261
SG&A expense$5.23M$4.47M$3.89M$2.80M$1.39M
Interest expense——$3,036$105,171$39,433
Net income-$7.59M-$7.77M-$6.66M-$5.68M-$3.24M
EPS (basic)-1.90-5.19-10.87-0.87—
EPS (diluted)-1.90-5.19-10.87-0.87—
Weighted avg. shares (diluted)3.99M1.50M613,0006.53M—
Balance sheet
Cash & equivalents$6.51M$2.63M$4.29M$3.59M$79,727
Receivables$142,152$107,918$93,211$110,258$43,394
Inventory$1.75M$831,757$533,239$94,701$275,501
Current assets$9.44M$9.24M$5.62M$4.24M$644,327
PP&E, net$61,777$107,562$154,848$119,744$20,284
Intangibles$559,968$451,302$286,429$137,557$87,306
Total assets$10.14M$9.84M$6.22M$4.69M$824,317
Current liabilities$1.05M$737,718$624,486$600,005$616,801
Total liabilities$1.07M$743,168$659,936$665,455$616,801
Shareholders' equity$9.07M$9.10M$5.56M$4.02M$207,516
Shares outstanding5.48M2.45M747,4167.31M6.06M
Cash flow statement
Operating cash flow-$7.28M-$6.74M-$5.77M-$3.22M-$1.21M
Capital expenditure$72,513$62,203$78,463$121,561$20,782
Free cash flow-$7.35M-$6.80M-$5.84M-$3.35M-$1.23M
Investing cash flow$4.48M-$5.16M-$198,753-$219,951-$118,454
Financing cash flow$6.68M$10.24M$6.66M$6.96M$1.39M
Depreciation & amortization$66,788$109,489$61,093$22,101$498
Stock-based compensation$738,170$774,788$936,769$1.47M$1.33M

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.